GoHealth
GOCO
GOCO was delisted on the 15th of June, 2026.
51 hedge funds and large institutions have $53.1M invested in GoHealth in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 5 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 8
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
13% more funds holding
Funds holding: 45 → 51 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.67% less ownership
Funds ownership: 55.56% → 54.89% (-0.67%)
6% less capital invested
Capital invested by funds: $56.6M → $53.1M (-$3.55M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$176K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$146K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$132K |
| 4 |
Invesco
Atlanta,
Georgia
|
+$123K |
| 5 |
BlackRock
New York
|
+$103K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$153K |
| 2 |
ABC
Associated Banc-Corp
Green Bay,
Wisconsin
|
-$59.3K |
| 3 |
JP Morgan Chase
New York
|
-$45.4K |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$26.6K |
| 5 |
AIG
American International Group
New York
|
-$21.5K |
GOCO Hedge Fund Activity: Q2 2024 in Review
51 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in GoHealth (GOCO) for Q2 2024, worth a combined $53.1M — down 6.3% from $56.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GOCO positions and 5 closed out — a net gain of 6 holders — while 18 added to existing stakes and 8 trimmed.
The largest buyer was UBS Group, adding an estimated $176K. The largest seller was Zacks Investment Management, exiting entirely with an estimated $153K sold.
- 51 institutional investors held GoHealth (GOCO) as of Q2 2024, up from 45 in Q1 2024.
- Funds reported $53.1M of GoHealth stock for Q2 2024, down 6.3% quarter-over-quarter.
- 11 funds opened new GoHealth positions in Q2 2024 and 5 closed out, a net change of +6 holders.
- The largest GoHealth buyer in Q2 2024 was UBS Group, an estimated $176K added.
- The largest GoHealth seller in Q2 2024 was Zacks Investment Management, an estimated $153K sold.
Based on aggregated 13F filings for Q2 2024.